X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
about
Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophyAbcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient miceABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesityEvaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy.Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.Brain endothelial dysfunction in cerebral adrenoleukodystrophy.Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatinEnhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages.ABCD2 is abundant in adipose tissue and opposes the accumulation of dietary erucic acid (C22:1) in fatX-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells.Uptake and metabolism of plasma-derived erucic acid by rat brain.Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
P2860
Q24618949-9C10066C-9A55-4EAD-BE30-BBAA3DA4EF1DQ34257373-4BF6A6A7-522F-4157-A49C-82676EE30971Q34360091-8FE41D9F-8497-4478-9E09-BA72E6C0994BQ35216369-3451FD09-A8AB-47EC-816D-7A0E439D4F04Q35225619-0FB6B91D-7D3E-4F91-BFDB-0EA3B7770207Q36515946-EEB08BEB-F642-4464-ADA0-A360D80270B8Q36953948-D3C489CD-9691-4ED7-ABB6-DFC5FDB6A048Q37035830-CA1C8EA8-F774-45BD-A9C9-7DF7B4A916F4Q37463266-312A8368-2C85-4A76-B718-260C72859AE6Q38806290-C9DD184B-006B-455A-A8A5-7F251F100122Q42212192-5D304263-F2DF-4542-A423-3AD490E72797Q46981518-7BBA3DBF-4F40-4329-887C-340EF00BBE99Q50276649-536F6597-9524-4405-8852-48A0CFF58DD4
P2860
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@en
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@nl
type
label
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@en
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@nl
prefLabel
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@en
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@nl
P2093
P2860
P1433
P1476
X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
@en
P2093
Isabelle Weinhofer
Markus Kunze
Sonja Forss-Petter
P2860
P304
P356
10.1016/J.FEBSLET.2005.09.014
P407
P577
2005-09-27T00:00:00Z